HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

Last update: 4 days ago, 4:08AM

36.98

0.93 (2.58%)

Previous Close 36.05
Open 35.43
Volume 31,350,958
Avg. Volume (3M) 28,511,955
Market Cap 8,206,728,704
Price / Earnings (TTM) 69.77
Price / Earnings (Forward) 56.18
Price / Sales 4.14
Price / Book 14.13
52 Weeks Range
19.29 (-47%) — 72.98 (97%)
Earnings Date 3 Nov 2025
Profit Margin 9.21%
Operating Margin (TTM) 10.12%
Diluted EPS (TTM) 0.680
Quarterly Revenue Growth (YOY) 110.70%
Quarterly Earnings Growth (YOY) 344.70%
Total Debt/Equity (MRQ) 11.54%
Current Ratio (MRQ) 1.59
Operating Cash Flow (TTM) 334.34 M
Levered Free Cash Flow (TTM) 213.45 M
Return on Assets (TTM) 10.76%
Return on Equity (TTM) 36.79%

Market Trend

Short Term Medium Term
Industry Household & Personal Products (US) Bearish Bearish
Household & Personal Products (Global) Bearish Bearish
Stock Hims & Hers Health, Inc. Bullish Bullish

AIStockmoo Score

0.8
Analyst Consensus 1.5
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 0.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HIMS 8 B - 69.77 14.13
ELF 5 B - 55.69 3.85
UL 149 B 1.55% 23.52 7.04
PG 347 B 0.68% 21.65 6.57
CL 64 B 0.63% 22.23 73.50
KMB 34 B 4.82% 17.54 25.91

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Sector Consumer Defensive
Industry Household & Personal Products
Investment Style Small Growth
% Held by Insiders 11.13%
% Held by Institutions 82.47%

Ownership

Name Date Shares Held
Farallon Capital Management Llc 30 Sep 2025 10,746,852
52 Weeks Range
19.29 (-47%) — 72.98 (97%)
Price Target Range
32.00 (-13%) — 85.00 (129%)
High 85.00 (BTIG, 129.85%) Buy
Median 68.00 (83.88%)
Low 32.00 (B of A Securities, -13.47%) Sell
Average 61.67 (66.77%)
Total 2 Buy, 1 Sell
Avg. Price @ Call 47.03
Firm Date Target Price Call Price @ Call
B of A Securities 04 Nov 2025 32.00 (-13.47%) Sell 42.79
BTIG 04 Nov 2025 85.00 (129.85%) Buy 42.79
Canaccord Genuity 12 Sep 2025 68.00 (83.88%) Buy 55.50

No data within this time range.

Date Type Details
18 Nov 2025 CNBC Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
13 Nov 2025 Announcement Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
03 Nov 2025 Announcement Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
02 Nov 2025 CNBC Where the blockbuster weight loss drug market stands today — and what’s coming next
17 Oct 2025 CNBC Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
15 Oct 2025 Announcement Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
13 Oct 2025 Announcement Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
09 Oct 2025 Announcement Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
10 Sep 2025 Announcement Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
26 Aug 2025 TheFinance 4 Attractive US Growth Stocks Set to Sizzle Up Your Investment Portfolio
25 Aug 2025 Announcement SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
22 Aug 2025 Announcement Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
21 Aug 2025 Announcement Investors SueWallSt as Hims & Hers Health, Inc. Faces Securities Fraud Allegations
21 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
20 Aug 2025 Announcement Tune Into the SueWallSt Podcast: Hims & Hers Health, Inc. (HIMS) Lawsuit Explained
19 Aug 2025 Announcement SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS)
19 Aug 2025 Announcement Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria